Axiomed announced it raised $70,000 in an initial filing from an offering of $12 Million

Company

Location

About

AxioMed was founded to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs. We passionately believe that next-generation lumbar and cervical total disc replacement (TDR) technology will transform the lives of patients on a global scale. Led by an experienced surgeon team utilizing patented viscoelastic polymer technology, AxioMed is developing the next generation of artificial discs.